Evaluation of clinical usefulness of PET/CT with aminoacid metabolism

Evaluation of clinical usefulness of PET/CT with aminoacid metabolism - Clinical value of methionine-PET/CT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004043

Enrollment

100

Registered

2010-09-01

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1.Parathyroid adenoma 2.Multiple myeloma 3.Brain tumor 4.Malignant tumors without FDG avidity

Interventions

PET/CT scan using 11C-methionine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Localization of parathyroid adenoma 2.Muliple myeloma 3.Brain tumor after treatment 4.Patients with

Exclusion criteria

Exclusion criteria: Patients with the following conditions: 1.Communication disturbance 2.Poor clinical status 3.Pregnancy

Design outcomes

Primary

Measure	Time frame
Diagnostic performance	—

Countries

Japan

Contacts

Public ContactYuji Nakmoto

Kyoto University Hospital Department of Diagnostic Radiology

ynakamo1@kuhp.kyoto-u.ac.jp075-751-3762

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026